Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions: Overweight; Obesity Intervention: Other: Source document data collection Sponsor: Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions: Overweight; Obesity Interventions: Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg; Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg; Drug: SIB Group Sibus (Sibutramine) 15mg; Drug: Placebo Group Sponsor: Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions: Overweight; Obesity Intervention: Other: Source document data collection Sponsor: Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions: Overweight; Obesity Interventions: Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg; Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg; Drug: SIB Group Sibus (Sibutramine) 15mg; Drug: Placebo Group Sponsor: Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions: Overweight; Obesity Intervention: Other: Source document data collection Sponsor: Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
Conditions: Overweight; Obesity Interventions: Drug: ADF1 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 75mg; Drug: ADF2 Group Eurofarma drug association of Sibutramine IR 15mg / Topiramate XR 100mg; Drug: SIB Group Sibus (Sibutramine) 15mg; Drug: Placebo Group Sponsor: Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity
Conditions: Overweight; Obesity Intervention: Other: Source document data collection Sponsor: Eurofarma Laboratorios S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Treatment of Binge Eating in Obese Patients in Primary Care
Conditions: Obesity; Binge EatingInterventions: Drug: Sibutramine; Drug: Placebo; Behavioral: Self-help CBT + Sibutramine; Behavioral: Self-help CBT + PlaceboSponsors: Yale University; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2007 Category: Research Source Type: clinical trials
A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
Conditions: Overweight; ObesityInterventions: Drug: pramlintide acetate; Drug: sibutramine; Drug: phentermine; Drug: placeboSponsor: AstraZenecaCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2006 Category: Research Source Type: clinical trials
